Could a gentle rocking bed boost memory and sleep for brain injury patients?
NCT ID NCT07658027
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study investigates whether sleeping on a gently rocking bed can improve sleep quality and memory in people undergoing neurorehabilitation after conditions like stroke, traumatic brain injury, or inflammatory diseases of the central nervous system. Participants will sleep on the rocking bed for 14 nights and undergo sleep assessments. The goal is to see if this simple, non-invasive approach can enhance standard memory training.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
rocking bed (Somnomat)
What this could lead to
If it works, this could offer a simple, drug-free way to boost memory and sleep quality for people recovering from brain injuries or diseases.
What could go wrong
This is a small early study with only 20 participants, and the rocking bed is not yet certified in Switzerland. Benefits are not guaranteed, and there are minor risks like falling or discomfort.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEMORY DEFICIT AQUIRED DUE TO THE DISEASE, E.G. STROKE, NEURODEGENERATION, INFLAMMATORY DISEASE OF CNS, TRAUMATIC BRAIN INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
cereneo Schweiz AG, Hertensteinstrasse 162 CH-6353
Weggis, 6353, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••